Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,848 | 88,115 | 0 | N/A | 0 |
| Marketable Securities | 70,508 | 32,048 | 0 | N/A | 0 |
| TOTAL | $112,161 | $122,632 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 4,767 | 5,050 | N/A | N/A | N/A |
| Other Non-Current Assets | 5,403 | 5,676 | 0 | 0 | 0 |
| TOTAL | $10,170 | $10,726 | $N/A | $N/A | $N/A |
| Total Assets | $122,331 | $133,358 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 763 | 1,080 | 0 | 0 | 0 |
| Accrued Expenses | 3,992 | 4,077 | 0 | N/A | 0 |
| Other current liabilities | 76 | 89 | 0 | N/A | 0 |
| TOTAL | $5,947 | $6,473 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,978 | 6,277 | 0 | 0 | 0 |
| TOTAL | $5,978 | $6,277 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,925 | $12,750 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,331 | 20,308 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 0 | N/A | 0 |
| Retained earnings | -81,710 | -70,741 | 0 | N/A | 0 |
| Other shareholders' equity | 78 | 37 | 0 | 0 | 0 |
| TOTAL | $110,406 | $120,608 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $122,331 | $133,358 | $0 | $0 | $0 |